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Primary  pericardial  synovial  sarcoma  is extremely  rare, with  few  published  cases  in  the  literature.  We
report  the  case  of  an  adolescent  aged  13  years  with  primary  pericardial  synovial  sarcoma  discovered
during  tamponade,  conﬁrmed  by  molecular  biology,  and  for whom  treatment  combined  radiosurgery
and  adjuvant  chemotherapy.  The  particularity  of  the case  we  are  reporting  stems  from  the  young  age  of
our patient  (13  years)  as well  as the  duration  of  remission,  which  is quite  long  (21 months)  prior  to  aynovial sarcoma
ericardium
reatment
rognosis
superior  mediastinal  relapse  compared  to cases  reported  in the  literature.
<Learning  objective:  Synovial  sarcoma  is difﬁcult  to diagnose  and  has  a poor  prognosis.  Here,  a  13-
year-old  diagnosed  with  primary  pericardial  synovial  sarcoma  was  treated  with  combined  radiosurgery
and  adjuvant  chemotherapy  leading  to continuous  remission  for 21 months.  This  regimen  could  be used
to  successfully  manage  future  patients.  Molecular  biology  is  useful  in  the diagnosis  of synovial  sarcoma
 of t(
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Synovial sarcoma is a highly malignant mesenchymal tumor
hat usually affects the deep soft tissues near the large joints of the
xtremities in adolescents and young adults [1,2]. Other atypical
rimary localizations have been described: head and neck, heart,
leura, abdomen, kidney, prostate, and vulva [1]. Pericardial local-
zation is extremely rare [3–6]. Only a few well-documented cases
ave been published [1,5–15]. In this manuscript we  report a new
ase.
ase reportA 13-year-old child, with no medical history, presented for con-
ultation in February 2011 in the emergency department for an
xertional dyspnea of sudden onset.
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ttp://dx.doi.org/10.1016/j.jccase.2013.09.005X;18)  translocation  in  atypical  locations  as  in  the  present  case.>
anese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.
The clinical examination found an orthopnea, tachycardia, and
pericardial friction rub on heart auscultation. The chest X-ray
showed a cardiomegaly, leading to his hospitalization in the depart-
ment of cardiovascular surgery.
The echocardiography showed pericardial effusion in the right
sub-costal area, as well as a 73 mm × 61 mm right lateral-atrial
intra-pericardial mass responsible for diastolic compression of the
right ventricle free wall (Fig. 1). Pericardial drainage brought 500 ml
of sero-hematic ﬂuid.
The chest computed tomography scan performed subsequently
showed an expansive intra-pericardial process in contact with the
right auricle and ventricle (Fig. 2a and b). The partial resection of
the intrapericardial tumor was  performed secondarily to prevent
heart failure and to gain a deﬁnitive diagnosis. Complete resection
of the tumor was impossible because of the intrapericardial
localization of the tumor. Histologically, it was a malignant tumor
proliferation arranged in bundles. The cells were often spindle-
shaped, with poorly deﬁned cytoplasm and elongated nuclei with
a ﬁne, dusty chromatin, and mitoses were common (Fig. 3a and b).
On immunostaining, cells were positive for epithelial membrane
antigen and vimentin but negative for pankeratin AE1/AE3, CD
34, CD 45, and chromogranin. Given these morphological and
vier Ltd. All rights reserved.
T. Chekrine et al. / Journal of Cardiology Cases 9 (2014) 40–43 41
F
(
i
g
N
d
(
6
e
e
t
t
F
e
rig. 1. Echocardiography showing a right lateral atrial intra-pericardial mass
white star).
mmunophenotypic aspects, a monophasic synovial sarcoma with
rade III malignancy according to the FNCLCC (French Fédération
ationale des Centres de Lutte Contre le Cancer)  system is given. The
iagnosis was  conﬁrmed by molecular cytogenetic examination
ﬂuorescence in situ hybridization; FISH), which showed that
5% of cells showed rearrangement of the SS18 locus molecular
quivalent of the characteristic t(X;18) translocation (Fig. 4). The
xamination for an extra-pericardial localization particularly in
he soft tissues came back negative.
Chemotherapy with four courses of ifosfamide and doxorubicin
reatment every three weeks was well tolerated. Radiographic
ig. 2. Chest computed tomography (CT) ﬁndings. (a) Plain and (b) contrast-
nhanced CT image. Intra-pericardial tumor in contact with the right atrium and
ight ventricle (arrow).Fig. 3. (a) Overview of spindle cell tumor inﬁltrating pericardium tissue
(hematoxylin–eosin, original 40×). (b) A photomicrograph of the primary pericardial
tumor showing fasciculi of the spindle cells (hematoxylin–eosin, original 400×).
evaluation revealed a tumor regression greater than 50%. The
patient received postoperative radiotherapy on the heart in total
at a dose of 30.6 Gy in 17 fractions with a double exposure on
the tumor bed at a dose of 19.6 Gy in 11 fractions. Monitoring by
echocardiography and electrocardiography during radiotherapy
Fig. 4. Fluorescence in situ hybridization analysis of the tumor (FISH): bi-color DNA
probe, Breakapart, SS18 locus rearrangement in 18q11.2 molecular equivalent of
the t(X;18) translocation (arrow).
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id not objectify speciﬁc abnormalities. The patient remained in
ontinuous remission for 21 months and the pericardial tumor
emained stable. The evolution was marked by an anterior superior
ediastinal relapse for which the child is receiving second-line
hemotherapy combining ifosfamide, carboplatin, and etoposide.
fter four cycles, the tumor response was less than 50%. The
eneral condition of the patient is currently under re-evaluation
y a team of supportive care.
iscussion
Pericardial tumors are extremely rare with an incidence of
.001–0.28% in some autopsy sets [5]. Metastatic lesions are
ore common than primary lesions [16]. These are dominated
y mesothelioma while primitive pericardial synovial sarcoma
s extremely rare [3–6] with only 17 cases reported to date in
he English literature (Table 1) [1,3,5–15]. Malignant spindle cell
umors, pericardial cysts, liposarcomas, lipomas, and teratomas
re other less common varieties of primitive pericardial tumors
14]. It is assumed that there is no direct relationship between the
ynovial tissue and synovial sarcoma, the tumor derived from a
ynovial differentiated pluripotent mesenchymal cell [17]. There
s a discreet male predominance, the sex ratio being 2.5/1 [1],
ith a higher incidence in the 3rd and 4th decade [3]. The aver-
ge age of patients at diagnosis is 39 years [1]. Our patient was
3 years old at diagnosis, the youngest among all cases reported
n the literature. Clinically, the symptoms are attributed to tam-
onade [1]. Dyspnea is by far the most common symptom. Other
ymptoms include chest pain, cough, and orthopnea [1,5]. The diag-
osis is usually established by trans-thoracic or trans-esophageal
able 1
rimary pericardial synovial sarcoma: summary of published studies.
Authors Sex/age
(y)
Tumor
size (cm)
Histological
subtype
Symptoms 
Al-Rajhi et al. (1999) [7] M/19 10 Biphasic Difﬁculty bre
Kojima  et al. (1999) [9] F/35 11 Monophasic Chest pain, n
dyspnea
Oizumi et al. (1999) [12] F/19 14 Biphasic Dyspnea, ast
Anand  et al. (2003) [8] M/29 8.5 Monophasic Difﬁculty bre
Van  Der Mieren et al.
(2004) [10]
M/26 NA Biphasic Tamponade 
Bégueret et al. (2005) [11] M/59 15 NA NA 
Schumann et al. (2007) [18] F/64 NA NA Difﬁculty bre
tachycardia
Hing  et al. (2007) [13] M/15 NA Biphasic Cough, tachy
weight loss
Korula  et al. (2009) [15] M/49 13 Monophasic Dyspnea, che
Katakura et al. (2009) [2] F/70 13 NA Cough, dyspn
Moorjani et al. (2009) [3] M/61 6 Biphasic Dyspnea, per
edema
Rangreze et al. (2011) [5] M/19 15 Monophasic Cough, dyspn
orthopnea
Akerström et al. (2011) [6] F/54 11 Biphasic Malaise, feve
pain
Cheng  et al. (2012) [1]
M/31 10 Biphasic Fever, cough
M/31  8 Monophasic Fever, night 
tachypnea, c
M/38 8 Monophasic Chest pain, d
breathing
Kodikara et al. (2012) [14] M/61 5 Biphasic Discovered a
autopsy
death/hyper
disease
Our  case M/13 7.3 Monophasic Dyspnea, ort
tachycardia
A: not available; CT: chemotherapy; RT: radiotherapy; t: translocation; M: male; F: femology Cases 9 (2014) 40–43
echocardiography, computed tomography, magnetic resonance
imaging, cytological examination of pericardial effusion, and peri-
cardial biopsy [5]. It is well established that magnetic resonance
imaging allows for a better assessment of heart and pericardial
tumors and distinguishes between benign and malignant tumors
[5,18]. It is effective in post-treatment monitoring [6,7]. Generally,
a pericardial mass associated with a pericardial effusion shows up.
Tumors vary in size from 6 to 15 cm (mean 10.6 cm) [1].
Histologically, synovial sarcomas are classiﬁed as biphasic,
monophasic, or poorly differentiated [1,6,14]. The biphasic variant
appears to be more common in the pericardial localization com-
pared to the other synovial sarcoma sites [1]. Most tumors carry a
characteristic t(X;18) translocation, which involves the genes SSX1
or SSX2 from the chromosome X (Xp11) and the gene SYT from the
chromosome 18 (18q11) [3]. More than 90% of patients with syno-
vial sarcoma have a t(X;18) translocation, which is not associated
with other sarcomas [1].
In the case we are reporting, cytogenetics conﬁrmed the
macroscopic and microscopic ﬁndings. The molecular diagnosis
is therefore essential especially when histological diagnosis is
difﬁcult. In addition to the case we  are reporting, 12 other cases
of primary pericardial synovial sarcomas reported in the literature
were conﬁrmed either by reverse transcription – polymerase chain
reaction (RT-PCR), or by FISH, or by both [1,2,7,9–13]. The FISH
technique has better sensitivity in the detection of the t(X;18)
translocation than RT-PCR, while the latter has the advantage of
identifying gene fusion transcripts [1]. The differential diagnosis
arises mainly with pericardial mesothelioma, which is usually
associated with a history of asbestos exposure and with a diffuse
inﬁltration of the pericardium. On the other hand, the synovial
Molecular
biology
Treatment Evolution
athing t(X,18) Surgery, RT In remission for 12 months
ausea, t(X,18) NA NA
henia t(X,18) Surgery Deceased after 7 months
athing Not performed Surgery–RT–CT In remission for 13 months
t(X,18) Surgery–CT–RT In remission for 14 years
t(X,18) NA NA
athing, Not performed Surgery NA
pnea, t(X,18) CT–surgery Deceased after 31 months
st pain Not performed Supportive care NA
ea t(X,18) Surgery, palliative
care
Deceased after 79 days
ipheral Not performed Surgery–CT In remission after 2 months
ea, Not performed Surgery–palliative
CT
In progress
r, chest t(X,18) Surgery–CT–RT In remission for 22 months
 t(X,18) CT–surgery In remission for 12 months
sweats,
hest pain
t(X,18) Surgery–CT Deceased after 27 months
ifﬁculty t(X,18) Waiting for a heart
transplant
In remission for 2 months
t
tensive
t(X,18) – –
hopnea, t(X,18) Surgery–CT–RT In remission for 21 months
anterior superior
mediastinal relapse
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arcoma is usually a solitary mass and not associated with a
istory of asbestos exposure [3]. Immunohistochemical and
olecular cytogenetic studies conﬁrm the diagnosis in cases of
oubt [1].
Given its rarity, synovial sarcoma of the pericardium is dif-
cult to diagnose, its primary character difﬁcult to conﬁrm. A
econdary pericardial lesion of soft tissue synovial sarcoma should
e excluded prior to maintaining its primary character [16]. In
ur case, the absence of an extra-pericardial tumor localization
t diagnosis and after 21 months of follow-up conﬁrms the pri-
ary character of the tumor. Because of the rarity of pericardial
ynovial sarcomas, there is no standard therapy. Treatment, as
n all soft tissue sarcomas, is multimodal combining surgery and
adiochemotherapy.
Complete surgery remains the primary treatment option
10,15]. External beam radiation therapy is given in the event of
ncomplete surgical excision, providing better local control [7,8,10].
hemotherapy is indicated in the event of unresectable tumors
ecause of its spread or metastases [10]. The use of doxorubicin
an be limited due to its cardiotoxicity. In our case, the combina-
ion of radio-surgery and chemotherapy allowed for loco-regional
ontrol with a follow-up of 21 months. Pazopanib, a multi-targeted
yrosine kinase inhibitor, is a new treatment option for patients
ith non-adipocytic, metastatic soft-tissue sarcoma after failure of
tandard chemotherapy [19].
Primary pericardial synovial sarcoma has a poor prognosis espe-
ially when complete surgical resection is not possible [8,18]. This is
xplained by the large size of the lesions and the difﬁculty achieving
omplete resection because of the anatomical position [1]. Overall,
urvival is short. The only exception is the case reported by Van
er Mieren of a 26-year-old patient, operated on for a biphasic
ericardial synovial sarcoma with microscopically healthy surgi-
al resection margins, having received adjuvant radiotherapy and
hemotherapy, and with a survival of 14 years [10]. In conclu-
ion, primary pericardial synovial sarcoma is an extremely rare
nd aggressive tumor, with difﬁcult diagnosis and poor progno-
is. The discovery of a pericardial lesion must ﬁrst eliminate a
econdary location. Molecular biology examination by searching
or the t(X,18) translocation characteristic contributes signiﬁcantly
o the diagnosis. The particularities of our observation stem from
he young age of our patient (13 years), while the average age
f reported cases is 39 years, and the relatively long duration of
emission of 21 months, following treatment combining surgery,
hemotherapy, and radiotherapy.onﬂict of interest
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